1.Association of VAMP-2 and Syntaxin 1A Genes with Adult Attention Deficit Hyperactivity Disorder.
Aye Nur Inci KENAR ; Ozlem Izci AY ; Hasan HERKEN ; Mehmet Emin ERDAL
Psychiatry Investigation 2014;11(1):76-83
OBJECTIVE: The etiology of attention deficit hyperactivity disorder (ADHD) has not been entirely clarified yet. Structural and metabolic differences at the prefrontal striatal cerebellary system and the interaction of gene and environment are the main factors that thought to play roles in the etiology. Genetic investigations are performed especially about the dopamine pathways and receptors. In this study; it was aimed to investigate the association of the synaptobrevin-2 (VAMP-2) gene Ins/Del polymorphism and syntaxin 1A gene intron 7 polymorphism, which take place in encoding presynaptic protein, with adult ADHD. METHODS: One hundred thirty-nine patients, having ADHD aging between 18 and 60 years and 106 healthy people as controls were included into the study. DNA samples were extracted from whole blood and genetic analysis were performed. RESULTS: A significant difference was determined between ADHD and VAMP-2 Ins/Del polymorphism and syntaxin 1A intron 7 polymorphism according to the control group. These polymorphisms were found not to be associated with subtypes of ADHD. CONCLUSION: It is supposed that synaptic protein genes together with dopaminergic genes might have roles in the etiology of ADHD.
Adult*
;
Aging
;
Attention Deficit Disorder with Hyperactivity*
;
DNA
;
Dopamine
;
Humans
;
Introns
;
Qa-SNARE Proteins*
;
Syntaxin 1*
;
Vesicle-Associated Membrane Protein 2*
2.Investigation of Dysregulation of Several MicroRNAs in Peripheral Blood of Schizophrenia Patients.
Mehmet Akif CAMKURT ; Fatih KARABABA ; Mehmet Emin ERDAL ; Hüseyin BAYAZIT ; Sultan Basmacı KANDEMIR ; Mustafa Ertan AY ; Hasan KANDEMIR ; Ozlem Izci AY ; Erdinç ÇIÇEK ; Salih SELEK ; Bahar TAŞDELEN
Clinical Psychopharmacology and Neuroscience 2016;14(3):256-260
OBJECTIVE: The prevalence of schizophrenia is 1%, and it is a debilitating disorder that often results in a shortened lifespan. Peripheral blood samples are good candidates to investigate because they can be easily drawn, and they are widely studied in psychiatric disorders. MicroRNAs are small non-coding RNA transcripts. They regulate the expression of genes by binding to the 3'-untranslated region (UTR) of mRNAs and pointing them to degrade. In this study, we aimed to investigate the expression of miR-9-5p, miR-29a-3p, miR-106-5p, miR-106b-5p, miR-107, miR-125a-3p, and miR-125b-3p in schizophrenia patients and healthy controls. METHODS: We collected blood samples from 16 patients with schizophrenia and 16 healthy controls. MicroRNAs were measured with reverse transcriptase polymerase chain reaction. RESULTS: Schizophrenia patients showed statistically significant upregulation of five microRNAs: miR9-5p (p=0.002), miR29a-3p (p<0.001), miR106b-5p (p=0.002), miR125a-3p (p<0.001), and miR125b-3p (p=0.018). CONCLUSION: Our results increased the value of the miR106 and miR29 families as potentially and consistently dysregulated in psychiatric disorders. Our results should be considered preliminary, and they need confirmation in future studies with larger sample sizes.
Humans
;
MicroRNAs*
;
Prevalence
;
Reverse Transcriptase Polymerase Chain Reaction
;
RNA, Messenger
;
RNA, Small Untranslated
;
Sample Size
;
Schizophrenia*
;
Up-Regulation
3.The Effect of Single Dose Methylphenidate on Neurometabolites according to COMT Gene Val158Met Polymorphism in the Patient with Attention Deficit Hyperactivity Disorder: A Study Using Magnetic Resonance Spectroscopy.
Onder OZTURK ; Huseyin ALACAM ; Burge Kabukcu BASAY ; Omer BASAY ; Ahmet BUBER ; Ozlem Izci AY ; Kadir AGLADIOGLU ; Mehmet Emin ERDAL ; Hasan HERKEN
Clinical Psychopharmacology and Neuroscience 2016;14(2):184-193
OBJECTIVE: Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder. Thus, the present study aimed to determine the effects of a single dose of methylphenidate (Mph) on neurometabolite levels according to polymorphisms of the catechol-O-methyltransferase (COMT) gene. METHODS: This study evaluated the neurometabolite levels including N-acetylaspartate (NAA), creatine (Cr), and choline (Cho) of ADHD patients, before and after treatment with Mph (10 mg) according to the presence of COMT polymorphisms. The spectra were obtained from the dorsolateral prefrontal cortex (DLPFC), anterior cingulate cortex (ACC), cerebellum, and striatum. RESULTS: The NAA levels of the val/val and val genotype carriers (val/val and val/met genotypes) increased in the DLPFC and ACC, respectively, following Mph treatment. The NAA/Cr ratio was lower in the DLPFC of val carriers than in the met/met genotype carriers prior to Mph administration. The Cho levels of the val/met genotype and val carriers increased in the striatum following Mph treatment. Following Mph treatment, the Cr levels of the met/met genotype carriers were higher than those of the val/met genotype and val carriers. Additionally, after Mph treatment, there was a significant increase in Cr levels in the DLPFC of the met/met genotype carriers but a significant decrease in such levels in the striatum of val/val genotype carriers. CONCLUSION: These findings suggest that polymorphisms of the COMT gene can account for individual differences in neuro-chemical responses to Mph among ADHD patients. Therefore, further studies are needed to fully characterize the effects of the Val158met polymorphism of the COMT gene on treatment outcomes in patients with ADHD.
Attention Deficit Disorder with Hyperactivity*
;
Catechol O-Methyltransferase
;
Cerebellum
;
Choline
;
Creatine
;
Genotype
;
Gyrus Cinguli
;
Humans
;
Individuality
;
Magnetic Resonance Spectroscopy*
;
Methylphenidate*
;
Prefrontal Cortex